FITB vs MRNA · P/E 17, rev $3.37B vs rev $145.0M
Fifth Third Bancorp (FITB) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the FITB and MRNA stock pages for the full models.
Not investment advice.